Trials / Completed
CompletedNCT01775579
Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium
Randomized, Open Label, Multiple-Dose, 6-sequence, 3-period, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
We investigate the potential pharmacokinetic drug-drug interaction between metformin extended release and rosuvastatin in healthy male volunteers who receive metformin extended release alone, rosuvastatin alone, and both together in a 3 period repeatedly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glucophage SR tablet 750 mg, Crestor tablet 20 mg |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-03-01
- Completion
- 2013-06-01
- First posted
- 2013-01-25
- Last updated
- 2013-08-23
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01775579. Inclusion in this directory is not an endorsement.